Excell Research   Report issue

For profit Phase 2
Founded: Oceanside CA United States (2004)
Status: Defunct (2015)

Organization Overview

First Clinical Trial
2010
NCT01246908
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now